Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Heavy Strength Training in Head and Neck Cancer Survivors
- Status
- RECRUITING
- Phase
- PHASE2
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing Radiotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
- Status
- RECRUITING
- Phase
- NA
Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Status
- RECRUITING
- Phase
- N/A
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
- Status
- RECRUITING
- Phase
- PHASE4
CD40 Agonist and PD-1 Inhibitor in HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1